GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $559,000 | -24.8% | 1,593,277 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $743,000 | -65.7% | 1,593,277 | 0.0% | 0.01% | -65.0% |
| Q1 2016 | $2,167,000 | -7.5% | 1,593,277 | 0.0% | 0.02% | -20.0% |
| Q4 2015 | $2,342,000 | -7.0% | 1,593,277 | 0.0% | 0.02% | -16.7% |
| Q3 2015 | $2,517,000 | -53.5% | 1,593,277 | -50.0% | 0.03% | -3.2% |
| Q2 2015 | $5,418,000 | +87.5% | 3,186,554 | +53.3% | 0.03% | -22.5% |
| Q1 2015 | $2,890,000 | +260.8% | 2,079,194 | +292.3% | 0.04% | +185.7% |
| Q4 2014 | $801,000 | -26.6% | 530,000 | 0.0% | 0.01% | -36.4% |
| Q3 2014 | $1,092,000 | -32.7% | 530,000 | 0.0% | 0.02% | -38.9% |
| Q2 2014 | $1,622,000 | -16.8% | 530,000 | 0.0% | 0.04% | -33.3% |
| Q1 2014 | $1,950,000 | -49.6% | 530,000 | -32.1% | 0.05% | -64.7% |
| Q4 2013 | $3,869,000 | +117.6% | 780,000 | 0.0% | 0.15% | +109.6% |
| Q3 2013 | $1,778,000 | +60.2% | 780,000 | +56.0% | 0.07% | +35.2% |
| Q2 2013 | $1,110,000 | – | 500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |